Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 9;19(1):954.
doi: 10.1186/s12879-019-4496-z.

Mumps: MMR vaccination and genetic diversity of mumps virus, 2007-2011 in Catalonia, Spain

Collaborators, Affiliations

Mumps: MMR vaccination and genetic diversity of mumps virus, 2007-2011 in Catalonia, Spain

Irene Barrabeig et al. BMC Infect Dis. .

Abstract

Background: Mumps is a vaccine-preventable disease but outbreaks have been reported in persons vaccinated with two doses of MMR vaccine. The objective was to describe the demographic features, vaccination effectiveness and genetic mumps virus diversity among laboratory-confirmed cases between 2007 and 2011 in Catalonia.

Methods: Cases and outbreaks of mumps notified to the notifiable diseases system of Catalonia between 2007 and 2011 retrospectively registered were included. Public health care centres provided written immunization records to regional public health staff to determine the vaccination history. Saliva and serum specimens were collected from suspected cases for laboratory-confirmation using real-time reverse-transcriptase PCR (rtRT-PCR) or serological testing. Phylogenetic analysis of the complete SH gene (316 nucleotides) and complete coding HN protein (1749 nucleotides) sequences was made. Categorical variables were compared using the Chi-square or Fisher's tests and continuous variables using the Student test. Vaccination effectiveness by number of MMR doses was estimated using the screening method.

Results: During the study period, 581 confirmed cases of mumps were notified (incidence rate 1.6 cases/100,000 persons-year), of which 60% were male. Three hundred sixty-four laboratory-confirmed cases were reported, of which 44% were confirmed by rtRT-PCR. Of the 289 laboratory-confirmed cases belonging to vaccination cohorts, 33.5% (97) had received one dose of MMR vaccine and 50% (145) two doses. Based on phylogenetic analyses of 316-nucleotide and 174-nucleotide SH sequences, the viruses belonging to viral genotypes were: genotype G (126), genotype D (23), genotype H (2), genotype F (2), genotype J (1), while one remained uncharacterized. Amino acid differences were detected between circulating strains and the Jeryl Lynn vaccine strains, although the majority of amino acid substitutions were genotype-specific. Fifty-one outbreaks were notified that included 324 confirmed mumps cases. Genotype G was the most frequent genotype detected. The family (35%), secondary schools (25%) and community outbreaks (18%) were the most frequent settings.

Conclusions: Our study shows that genotype G viruses are the most prevalent in Catalonia. Most cases occurred in people who had received two doses of MMR, suggesting inadequate effectiveness of the Jeryl Lynn vaccine strain. The possible factors related are discussed.

Keywords: Genotypes; Laboratory diagnosis; MMR vaccine; Molecular surveillance; Mumps virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Phylogenetic reconstruction of complete coding SH gene. The strains in the present study are coloured by year: 2007 (orange), 2008 (red), 2009 (pink), 2010 (blue) and 2011 (brown)
Fig. 2
Fig. 2
Distribution of outbreaks of mumps and outbreak-related cases according to genotype and year of detection. Catalonia 2007–2011. Others: Genotype F, Genotype H and Genotype J

Similar articles

Cited by

References

    1. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine. 2009;27:6186–6195. doi: 10.1016/j.vaccine.2009.06.109. - DOI - PubMed
    1. World Health Organization Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012;22:217–224. - PubMed
    1. Rubin SA. Mumps vaccine. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Vaccines. 7. Philadelphia: Elsevier Inc; 2018. pp. 663–688.
    1. Šantak M, Lang-Balija M, Ivancic-Jelecki J, Košutić-Gulija T, Ljubin-Sternak S, Forcic D. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies. Epidemiol Infect. 2013;141:1298–1309. doi: 10.1017/S0950268812001896. - DOI - PMC - PubMed
    1. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JMH, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358:1580–1589. doi: 10.1056/NEJMoa0706589. - DOI - PubMed

MeSH terms

Substances